FDA News

Latest News

FDA Approves Bimekizumab for Adults with Hidradenitis Suppurativa
FDA Approves Bimekizumab for Adults with Hidradenitis Suppurativa

November 20th 2024

UCB has announced the FDA’s approval of bimekizumab, also known as Bimzelx, for patients with moderate-to-severe HS.

FDA Accepts Resubmitted sBLA for Dupilumab Treatment of Chronic Spontaneous Urticaria
FDA Accepts Resubmitted sBLA for Dupilumab Treatment of Chronic Spontaneous Urticaria

November 15th 2024

FDA Accepts Resubmission of Pz-cel Gene Therapy BLA for Epidermolysis Bullosa
FDA Accepts Resubmission of Pz-cel Gene Therapy BLA for Epidermolysis Bullosa

November 13th 2024

FDA black and white logo | Credit: US Food and Drug Administration
FDA Issues CRL to Obeticholic Acid (Ocaliva), Denies Full Approval for PBC

November 12th 2024

FDA Suggests Removing Oral Phenylephrine as OTC Monograph Nasal Decongestant Ingredient
FDA Suggests Removing Oral Phenylephrine as OTC Monograph Nasal Decongestant Ingredient

November 7th 2024

<1
...
7891011
© 2024 MJH Life Sciences

All rights reserved.